| Generic Name | Trametinib |
| Trade Name | Trametinib |
| Company Name | Novartis |
| Drug Type | Small molecule |
| Drug Class | MEK |
| Dose | 2.0 milligrams (mg) per flat dose |
| Route | Oral (p.o.) |
| Schedule of Administration | Trametinib 2.0 mg daily on days 1–28 of 28‐day cycle, repeated until progression or unacceptable toxicity, with dose adjustments based on tolerability |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.